8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2020 / Comprehensive narrative review
This comprehensive review analyzed articles published in PubMed since the 1960s covering experimental animal and human research on xylitol and erythritol. The review evaluated the anti-diabetic and antihyperglycemic effects, underlying mechanisms, and other metabolic effects of these sugar substitutes. The authors note the review aims to clarify controversies and aid in exploring their use as anti-diabetic supplements in food products.
Wölnerhanssen BK, Meyer-Gerspach AC, Beglinger C, et al. Crit Rev Food Sci Nutr, 2020. PMID 31204494
2020 / Narrative review
This review explores the bioactivity, clinical application, phytochemicals, products, markets, and patents related to fenugreek. More than 100 phytochemicals have been isolated from fenugreek seeds, mainly comprising polysaccharides, saponins, alkaloids, phenolic acids, and flavonoids. Fenugreek extract and its bioactive compounds showed antidiabetic and anti-obesity activity in both animal and human studies. The authors note that China currently lacks research on fenugreek in both depth and width.
Yao D, Zhang B, Zhu J, et al. Crit Rev Food Sci Nutr, 2020. PMID 31286789
2020 / Narrative review / historical overview
This review discusses the use of short-term dietary oatmeal interventions, a concept first described over 100 years ago by Carl von Noorden and still used in modified forms in German hospitals. Modern versions typically omit butter to provide a short-term, hypocaloric, low-fat, plant-based diet free of animal protein. The intervention has been associated with significant reductions in mean blood glucose concentrations and improved insulin sensitivity in patients with type 2 diabetes.
Shows an association, not proof of cause and effect.
Storz MA, Iraci F Can J Diabetes, 2020. PMID 31866240
2020 / Narrative review
This review examined studies addressing mortality, health-span, and longevity-enhancing mechanisms in vegans and vegetarians. Epidemiologic studies consistently show lower disease rates, such as lower cancer and cardiovascular disease incidence, but mortality rates are comparable to vegetarians and occasional meat eaters. Vegan diets improve insulin resistance and dyslipidemia, and features like protein restriction or amino acid restriction (leucine or methionine) show potential life-span-enhancing effects. The review notes that vegan diets do not meet the nutritional requirements of children, pregnant women, or elderly individuals without adequate supplementation.
Shows an association, not proof of cause and effect.
Norman K, Klaus S Curr Opin Clin Nutr Metab Care, 2020. PMID 31895244
2020 / Narrative review / methodological commentary
This commentary assesses the NutriRECS consortium's recommendations on red and processed meat, arguing their evaluation relied on GRADE criteria primarily designed for clinical drug trials rather than dietary exposures. Applying the NutriGRADE system, the evidence on the positive association between red and processed meats and type 2 diabetes was rated 'high quality,' and the association with mortality was rated 'moderate quality.' The authors note NutriRECS's evaluation also suffered from inadequate attention to what foods replace red meat, such as plant-based proteins or refined carbohydrates.
Shows an association, not proof of cause and effect.
Qian F, Riddle MC, Wylie-Rosett J, et al. Diabetes Care, 2020. PMID 31959642
2020 / Review of randomized controlled trials
This review evaluated randomized controlled intervention studies published in MEDLINE over a 5-year period examining dietary interventions and oxidative stress markers in subjects with obesity, hypertension, diabetes, or dyslipidemia. The review found that food antioxidants, hypocaloric diets with loss of adipose tissue, substitution of animal protein with vegetable protein, and changes in the microbiota improve antioxidant status in people with chronic metabolic conditions. Consumption of foods high in antioxidants and polyphenols increases plasma antioxidant capacity and lowers oxidative stress markers in these populations.
Ávila-Escalante ML, Coop-Gamas F, Cervantes-Rodríguez M, et al. J Food Biochem, 2020. PMID 32160647
2020 / Narrative review
This narrative review summarizes findings on resveratrol from epidemiological surveys, experimental studies, and clinical trials. The authors report that resveratrol exhibits antioxidant, anti-inflammatory, immunomodulatory, glucose and lipid regulatory, neuroprotective, and cardiovascular protective effects. Based on these mechanisms, it is noted to protect against diverse chronic conditions including cardiovascular diseases, cancer, liver diseases, obesity, diabetes, Alzheimer's disease, and Parkinson's disease.
Meng X, Zhou J, Zhao CN, et al. Foods, 2020. PMID 32183376
2020 / Narrative review
This review examines the potential of a whole food plant-based (WFPB) diet to ameliorate chronic kidney disease (CKD). Evidence suggests a WFPB diet may slow CKD progression, decrease cardiovascular disease incidence, lower rates of diabetes and obesity, and reduce inflammation and cholesterol, thereby delaying kidney failure and dialysis initiation. Plant-based protein is reported to be alkaline-producing, anti-inflammatory, and renoprotective, contrasting with animal protein which promotes acidity, inflammation, and hyperfiltration. The authors note that macronutrient and micronutrient content must be carefully adjusted to prevent malnutrition, and further research is required to confirm biological plausibility and feasibility in CKD patients.
Adair KE, Bowden RG Nutrients, 2020. PMID 32268544
2020 / Narrative review
This review discusses the impact of nutrition on COVID-19 susceptibility and outcomes. Consumption of a Western diet rich in saturated fats, sugars, and refined carbohydrates contributes to obesity and type 2 diabetes, which may place individuals at higher risk for severe COVID-19 pathology and death. The authors note that a Western diet activates innate immunity, impairs adaptive immunity, and leads to chronic inflammation and compromised viral defenses, while post-infection neuroinflammation could increase risks for conditions like dementia.
Butler MJ, Barrientos RM Brain Behav Immun, 2020. PMID 32311498
2020 / Narrative review
This review summarizes recent findings on mammalian erythritol metabolism and its role as a predictive biomarker for cardiometabolic disease risk. Elevated serum erythritol predicts future central adiposity gain and type 2 diabetes mellitus in healthy adults. Erythritol is an endogenously synthesized product of glucose via the pentose phosphate pathway, with the final conversion catalyzed by sorbitol dehydrogenase and alcohol dehydrogenase 1. Additionally, dietary erythritol can be metabolized to erythrose or erythronate in humans before excretion, highlighting the need to evaluate the effects of long-term consumption.
Shows an association, not proof of cause and effect.
Ortiz SR, Field MS Curr Opin Clin Nutr Metab Care, 2020. PMID 32412980
2020 / Guideline
The American Cancer Society updated its Diet and Physical Activity Guideline based on current scientific evidence regarding dietary and physical activity patterns and cancer risk. The guideline presents 4 recommendations for individual choices alongside recommendations for community action to create supportive environments. These recommendations align with prevention guidelines for coronary heart disease and diabetes from the American Heart Association and the American Diabetes Association.
Rock CL, Thomson C, Gansler T, et al. CA Cancer J Clin, 2020. PMID 32515498
2020 / Narrative review
This review examined literature from PubMed, guideline reports, and newer publications regarding hypertension and COVID-19 in African Americans. It highlights that the increased prevalence and risks of hypertension are primarily due to environmental and lifestyle factors, such as poor diet and adverse social determinants. Blood pressure control can be supported through lifestyle changes, including a low-sodium diet, weight loss, and physical activity, alongside pharmacological or novel treatments when needed. Additionally, existing comorbidities like hypertension and obesity contribute to worse COVID-19 outcomes in this population.
Ferdinand K, Batieste T, Fleurestil M J Natl Med Assoc, 2020. PMID 32563685
2020 / Narrative review / commentary
This commentary examines the Healthy Drinks, Healthy Kids guidelines that recommend children aged 12 to 24 months consume 2-3 cups of whole cow's milk daily and avoid plant-based milks other than soy. The authors contend that post-weaning, milk of any kind is not required if children have water and a balanced diet. They note cow's milk does not clearly reduce fractures and carries risks such as potential links to type 1 diabetes onset, toddler anemia, lactose intolerance, protein allergy, and colic. Meanwhile, risks from plant-based milks mainly arise when used inappropriately in unbalanced diets.
Wright NS, Smith M Matern Child Health J, 2020. PMID 32602067
2020 / Narrative review with systematic search
This narrative review systematically searched and appraised studies examining associations between ultra-processed food (UPF) intake and health outcomes in healthy participants. Out of 43 reviewed studies, 37 found UPF exposure was associated with at least one adverse health outcome. In adults, reported associations included overweight, obesity, cardio-metabolic risks, cancer, type-2 diabetes, cardiovascular diseases, irritable bowel syndrome, depression, frailty conditions, and all-cause mortality; in children and adolescents, outcomes included cardio-metabolic risks and asthma. No study reported an association between UPF and beneficial health outcomes, and the authors note that most findings were derived from observational studies.
Shows an association, not proof of cause and effect.
Elizabeth L, Machado P, Zinöcker M, et al. Nutrients, 2020. PMID 32630022
2020 / Narrative review
This review examines the impact of high-protein diets on renal function and longevity. High dietary protein intake can induce intraglomerular hypertension, leading to kidney hyperfiltration, glomerular injury, and proteinuria, with the potential to cause de novo CKD. In several observational studies, including the Singapore Chinese Health Study, animal protein intake was associated with an increased risk of ESKD compared to plant protein. The authors note conflicting evidence from trials and possible residual confounding in observational studies, calling for long-term, large-scale studies.
Shows an association, not proof of cause and effect.
Ko GJ, Rhee CM, Kalantar-Zadeh K, et al. J Am Soc Nephrol, 2020. PMID 32669325
2020 / Narrative review
This narrative review summarizes current evidence regarding the neuroendocrine and metabolic effects of low- and non-calorie sweeteners, including their impact on the central nervous system, gut hormones, and gut microbiota. While sweeteners may help reduce calorie intake and prevent weight gain, studies examining their short- and long-term safety and efficacy are scarce and controversial. The authors note the need for future studies to elucidate beneficial and detrimental effects across healthy populations and those with metabolic disorders, and discuss sweetener use in very-low calorie ketogenic diets.
Moriconi E, Feraco A, Marzolla V, et al. Front Endocrinol (Lausanne), 2020. PMID 32765425
2020 / Literature review
A literature review evaluated recent meta-analyses of longitudinal observational studies and clinical trials assessing vitamin D and incident diabetes. Longitudinal observational studies reported consistent associations between higher blood 25(OH)D levels and lower incident diabetes risk across diverse populations. In three large trials designed for diabetes prevention, vitamin D supplementation lowered diabetes risk by 10% to 13% compared with placebo in people with prediabetes who were not selected for vitamin D deficiency.
Pittas AG, Jorde R, Kawahara T, et al. J Clin Endocrinol Metab, 2020. PMID 32844212
2019 / Narrative review
This review summarizes evidence on plant sterol and stanol (PS) fortified foods for managing hypercholesterolemia. Meta-analyses of over 100 controlled clinical trials demonstrate that 2-3 g per day of PS yields a 9-12% reduction in LDL-cholesterol. In patients taking statins, the average LDL reduction with PS equals up-titrating the statin dose twice. A key limitation noted is the current lack of clinical trials evaluating the effects of PS on cardiovascular events.
Cofán M, Ros E Curr Med Chem, 2019. PMID 29984649
2019 / Narrative review
Following a James Lind Alliance survey identifying diabetes reversal as the top research priority among people with type 2 diabetes, this review summarizes current evidence on weight loss-induced remission. Current data indicate long-term stable β-cell function occurs if weight regain is prevented, whereas returning to previous weight leads to recurrence. The review also notes that the chance of achieving reversal steadily diminishes with increasing duration of type 2 diabetes.
Taylor R, Barnes AC Diabet Med, 2019. PMID 30378706
2019 / Clinical review of clinical trials
This review examined clinical trials on Berberis vulgaris and its alkaloid constituent berberine across electronic databases. Across 77 human clinical studies, lipid-lowering and insulin-resistance improving actions were the most frequently studied properties, alongside cardiovascular, anticancer, gastrointestinal, CNS, and endocrine applications. Berberine demonstrated very low toxicity at usual doses with no major side effects, though mild gastrointestinal reactions occurred in some patients.
Imenshahidi M, Hosseinzadeh H Phytother Res, 2019. PMID 30637820
2019 / Narrative review
This review discusses a series of studies showing that accumulation of fat in the liver and pancreas leads to beta cell dedifferentiation and type 2 diabetes. Normal blood glucose can be restored by removing excess fat from these organs through substantial weight loss. The resulting post-diabetes state can be long-term provided weight regain is avoided.
Taylor R Clin Med (Lond), 2019. PMID 30651243
2019 / Narrative review of clinical trials
This review evaluates clinical evidence on the polyphenolic nutraceutical resveratrol, whose efficacy, safety, and pharmacokinetics have been documented in over 244 clinical trials with 27 ongoing. Resveratrol is reported to potentially improve therapeutic outcomes in conditions such as diabetes mellitus, obesity, cancers, metabolic syndrome, hypertension, Alzheimer's disease, cardiovascular diseases, and kidney diseases. It is reported to be safe at doses up to 5 g/day alone or in combination therapy. However, its therapeutic use is limited by rapid metabolism and poor bioavailability, though a micronized formulation (SRT501) shows promise.
Singh AP, Singh R, Verma SS, et al. Med Res Rev, 2019. PMID 30741437
2019 / Narrative review
This review discusses clinical and pathophysiological studies showing that type 2 diabetes is largely driven by reversible fat accumulation in the liver and pancreas. Removal of this excess fat through substantial weight loss can normalize hepatic insulin responsiveness and allow recovery of acute insulin secretion by beta cells, normalizing blood glucose. In the primary care-based DiRECT trial, weight loss mediated type 2 diabetes remission in 46% of individuals at 12 months and 36% at 24 months.
Taylor R, Al-Mrabeh A, Sattar N Lancet Diabetes Endocrinol, 2019. PMID 31097391
2019 / Case report and literature review
A 54-year-old female presenting with grade 3 obesity (BMI 45.2 kg/m2), type II diabetes (A1c 8.1%), and heart failure with depressed left ventricular systolic function transitioned to a whole food plant-based diet alongside guideline-directed medical therapy. Over five and a half months, she lost 22.7 kg, reversed her diabetes without diabetes medications, and normalized her left ventricular systolic function. The authors noted that causality cannot be determined from this case report.
Allen KE, Gumber D, Ostfeld RJ Front Nutr, 2019. PMID 31245377